nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.262	0.633	CbGaD
Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.152	0.367	CbGaD
Methylprednisolone—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0496	0.133	CbGbCtD
Methylprednisolone—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0442	0.118	CbGbCtD
Methylprednisolone—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0319	0.0854	CbGbCtD
Methylprednisolone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0297	0.0794	CbGbCtD
Methylprednisolone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0265	0.0708	CbGbCtD
Methylprednisolone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0242	0.0648	CbGbCtD
Methylprednisolone—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.022	0.0587	CbGbCtD
Methylprednisolone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0212	0.0566	CbGbCtD
Methylprednisolone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0191	0.0512	CbGbCtD
Methylprednisolone—ABCB1—Glyburide—type 2 diabetes mellitus	0.0164	0.0437	CbGbCtD
Methylprednisolone—ABCB1—Losartan—type 2 diabetes mellitus	0.015	0.04	CbGbCtD
Methylprednisolone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0145	0.0388	CbGbCtD
Methylprednisolone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0139	0.0372	CbGbCtD
Methylprednisolone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0139	0.0372	CbGbCtD
Methylprednisolone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0132	0.0352	CbGbCtD
Methylprednisolone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0098	0.0262	CbGbCtD
Methylprednisolone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00896	0.024	CbGbCtD
Methylprednisolone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.000463	0.0853	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—HSD3B2—type 2 diabetes mellitus	0.000349	0.0643	CrCbGaD
Methylprednisolone—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000143	0.0263	CrCbGaD
Methylprednisolone—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000138	0.0255	CrCbGaD
Methylprednisolone—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000138	0.0255	CrCbGaD
Methylprednisolone—Desonide—NR3C1—type 2 diabetes mellitus	0.000131	0.0241	CrCbGaD
Methylprednisolone—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000131	0.0241	CrCbGaD
Methylprednisolone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000128	0.0235	CrCbGaD
Methylprednisolone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000126	0.0232	CrCbGaD
Methylprednisolone—Fludrocortisone—AR—type 2 diabetes mellitus	0.000124	0.0229	CrCbGaD
Methylprednisolone—Medrysone—NR3C1—type 2 diabetes mellitus	0.000116	0.0213	CrCbGaD
Methylprednisolone—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000112	0.0206	CrCbGaD
Methylprednisolone—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.00011	0.0202	CrCbGaD
Methylprednisolone—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000108	0.0199	CrCbGaD
Methylprednisolone—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000108	0.0199	CrCbGaD
Methylprednisolone—Cortisone acetate—NR3C1—type 2 diabetes mellitus	0.000106	0.0196	CrCbGaD
Methylprednisolone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000102	0.000629	CcSEcCtD
Methylprednisolone—Erythema—Losartan—type 2 diabetes mellitus	0.000102	0.000629	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000102	0.000627	CcSEcCtD
Methylprednisolone—Headache—Glipizide—type 2 diabetes mellitus	0.000102	0.000626	CcSEcCtD
Methylprednisolone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000102	0.000625	CcSEcCtD
Methylprednisolone—Shock—Valsartan—type 2 diabetes mellitus	0.000102	0.000624	CcSEcCtD
Methylprednisolone—Infection—Orlistat—type 2 diabetes mellitus	0.000101	0.000623	CcSEcCtD
Methylprednisolone—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000101	0.000622	CcSEcCtD
Methylprednisolone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000101	0.000622	CcSEcCtD
Methylprednisolone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000101	0.00062	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000101	0.00062	CcSEcCtD
Methylprednisolone—Budesonide—NR3C1—type 2 diabetes mellitus	0.000101	0.0185	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—SHBG—type 2 diabetes mellitus	0.000101	0.0185	CrCbGaD
Methylprednisolone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.0001	0.000617	CcSEcCtD
Methylprednisolone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.0001	0.000617	CcSEcCtD
Methylprednisolone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.0001	0.000615	CcSEcCtD
Methylprednisolone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.0001	0.000615	CcSEcCtD
Methylprednisolone—Hypertension—Metformin—type 2 diabetes mellitus	9.95e-05	0.000611	CcSEcCtD
Methylprednisolone—Urticaria—Glyburide—type 2 diabetes mellitus	9.95e-05	0.000611	CcSEcCtD
Methylprednisolone—Angioedema—Irbesartan—type 2 diabetes mellitus	9.94e-05	0.000611	CcSEcCtD
Methylprednisolone—Skin disorder—Orlistat—type 2 diabetes mellitus	9.91e-05	0.000609	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	9.91e-05	0.000609	CcSEcCtD
Methylprednisolone—Abdominal pain—Glyburide—type 2 diabetes mellitus	9.9e-05	0.000608	CcSEcCtD
Methylprednisolone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000608	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	9.87e-05	0.000606	CcSEcCtD
Methylprednisolone—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.83e-05	0.000604	CcSEcCtD
Methylprednisolone—Myalgia—Metformin—type 2 diabetes mellitus	9.81e-05	0.000603	CcSEcCtD
Methylprednisolone—Malaise—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.000603	CcSEcCtD
Methylprednisolone—Vertigo—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.0006	CcSEcCtD
Methylprednisolone—Headache—Pioglitazone—type 2 diabetes mellitus	9.76e-05	0.0006	CcSEcCtD
Methylprednisolone—Syncope—Irbesartan—type 2 diabetes mellitus	9.75e-05	0.000599	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	9.74e-05	0.000599	CcSEcCtD
Methylprednisolone—Visual impairment—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000597	CcSEcCtD
Methylprednisolone—Discomfort—Metformin—type 2 diabetes mellitus	9.69e-05	0.000596	CcSEcCtD
Methylprednisolone—Fatigue—Gliclazide—type 2 diabetes mellitus	9.69e-05	0.000596	CcSEcCtD
Methylprednisolone—Nausea—Glipizide—type 2 diabetes mellitus	9.66e-05	0.000594	CcSEcCtD
Methylprednisolone—Vomiting—Glimepiride—type 2 diabetes mellitus	9.65e-05	0.000593	CcSEcCtD
Methylprednisolone—Hypotension—Valsartan—type 2 diabetes mellitus	9.65e-05	0.000593	CcSEcCtD
Methylprednisolone—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.62e-05	0.000591	CcSEcCtD
Methylprednisolone—Rash—Glimepiride—type 2 diabetes mellitus	9.57e-05	0.000588	CcSEcCtD
Methylprednisolone—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.56e-05	0.000588	CcSEcCtD
Methylprednisolone—Mometasone—NR3C1—type 2 diabetes mellitus	9.56e-05	0.0176	CrCbGaD
Methylprednisolone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000587	CcSEcCtD
Methylprednisolone—Rash—Sitagliptin—type 2 diabetes mellitus	9.54e-05	0.000586	CcSEcCtD
Methylprednisolone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.53e-05	0.000586	CcSEcCtD
Methylprednisolone—Headache—Glimepiride—type 2 diabetes mellitus	9.51e-05	0.000584	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.5e-05	0.000584	CcSEcCtD
Methylprednisolone—Headache—Sitagliptin—type 2 diabetes mellitus	9.48e-05	0.000583	CcSEcCtD
Methylprednisolone—Rimexolone—NR3C1—type 2 diabetes mellitus	9.45e-05	0.0174	CrCbGaD
Methylprednisolone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.41e-05	0.000578	CcSEcCtD
Methylprednisolone—Hypertension—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000577	CcSEcCtD
Methylprednisolone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.37e-05	0.000576	CcSEcCtD
Methylprednisolone—Angioedema—Losartan—type 2 diabetes mellitus	9.35e-05	0.000575	CcSEcCtD
Methylprednisolone—Infection—Metformin—type 2 diabetes mellitus	9.34e-05	0.000574	CcSEcCtD
Methylprednisolone—Insomnia—Valsartan—type 2 diabetes mellitus	9.34e-05	0.000574	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.3e-05	0.000571	CcSEcCtD
Methylprednisolone—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.27e-05	0.00057	CcSEcCtD
Methylprednisolone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.26e-05	0.000569	CcSEcCtD
Methylprednisolone—Myalgia—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000569	CcSEcCtD
Methylprednisolone—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000569	CcSEcCtD
Methylprednisolone—Shock—Metformin—type 2 diabetes mellitus	9.25e-05	0.000569	CcSEcCtD
Methylprednisolone—Insomnia—Orlistat—type 2 diabetes mellitus	9.23e-05	0.000567	CcSEcCtD
Methylprednisolone—Malaise—Losartan—type 2 diabetes mellitus	9.23e-05	0.000567	CcSEcCtD
Methylprednisolone—Anxiety—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.000567	CcSEcCtD
Methylprednisolone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.22e-05	0.000567	CcSEcCtD
Methylprednisolone—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.22e-05	0.000567	CcSEcCtD
Methylprednisolone—Vertigo—Losartan—type 2 diabetes mellitus	9.2e-05	0.000565	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.2e-05	0.000565	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.000565	CcSEcCtD
Methylprednisolone—Syncope—Losartan—type 2 diabetes mellitus	9.18e-05	0.000564	CcSEcCtD
Methylprednisolone—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.16e-05	0.000563	CcSEcCtD
Methylprednisolone—Discomfort—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.000562	CcSEcCtD
Methylprednisolone—Skin disorder—Metformin—type 2 diabetes mellitus	9.14e-05	0.000561	CcSEcCtD
Methylprednisolone—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.11e-05	0.00056	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.09e-05	0.000559	CcSEcCtD
Methylprednisolone—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000559	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000558	CcSEcCtD
Methylprednisolone—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.06e-05	0.000557	CcSEcCtD
Methylprednisolone—Nausea—Glimepiride—type 2 diabetes mellitus	9.02e-05	0.000554	CcSEcCtD
Methylprednisolone—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000553	CcSEcCtD
Methylprednisolone—Loss of consciousness—Losartan—type 2 diabetes mellitus	9e-05	0.000553	CcSEcCtD
Methylprednisolone—Nausea—Sitagliptin—type 2 diabetes mellitus	8.99e-05	0.000552	CcSEcCtD
Methylprednisolone—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000552	CcSEcCtD
Methylprednisolone—Asthenia—Glyburide—type 2 diabetes mellitus	8.98e-05	0.000552	CcSEcCtD
Methylprednisolone—Urticaria—Gliclazide—type 2 diabetes mellitus	8.93e-05	0.000549	CcSEcCtD
Methylprednisolone—Fluocinonide—NR3C1—type 2 diabetes mellitus	8.92e-05	0.0164	CrCbGaD
Methylprednisolone—Fatigue—Valsartan—type 2 diabetes mellitus	8.91e-05	0.000547	CcSEcCtD
Methylprednisolone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.89e-05	0.000546	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000545	CcSEcCtD
Methylprednisolone—Pruritus—Glyburide—type 2 diabetes mellitus	8.86e-05	0.000544	CcSEcCtD
Methylprednisolone—Mental disorder—Ramipril—type 2 diabetes mellitus	8.83e-05	0.000543	CcSEcCtD
Methylprednisolone—Infection—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000542	CcSEcCtD
Methylprednisolone—Medroxyprogesterone Acetate—AR—type 2 diabetes mellitus	8.82e-05	0.0162	CrCbGaD
Methylprednisolone—Fatigue—Orlistat—type 2 diabetes mellitus	8.8e-05	0.000541	CcSEcCtD
Methylprednisolone—Hypotension—Metformin—type 2 diabetes mellitus	8.79e-05	0.00054	CcSEcCtD
Methylprednisolone—Erythema—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000539	CcSEcCtD
Methylprednisolone—Malnutrition—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000539	CcSEcCtD
Methylprednisolone—Shock—Irbesartan—type 2 diabetes mellitus	8.73e-05	0.000537	CcSEcCtD
Methylprednisolone—Myalgia—Losartan—type 2 diabetes mellitus	8.71e-05	0.000535	CcSEcCtD
Methylprednisolone—Arthralgia—Losartan—type 2 diabetes mellitus	8.71e-05	0.000535	CcSEcCtD
Methylprednisolone—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.71e-05	0.000535	CcSEcCtD
Methylprednisolone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000535	CcSEcCtD
Methylprednisolone—Anxiety—Losartan—type 2 diabetes mellitus	8.68e-05	0.000534	CcSEcCtD
Methylprednisolone—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	8.67e-05	0.016	CrCbGaD
Methylprednisolone—Alclometasone—NR3C1—type 2 diabetes mellitus	8.67e-05	0.016	CrCbGaD
Methylprednisolone—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.66e-05	0.000532	CcSEcCtD
Methylprednisolone—Rash—Bromocriptine—type 2 diabetes mellitus	8.64e-05	0.000531	CcSEcCtD
Methylprednisolone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.63e-05	0.00053	CcSEcCtD
Methylprednisolone—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.00053	CcSEcCtD
Methylprednisolone—Discomfort—Losartan—type 2 diabetes mellitus	8.61e-05	0.000529	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000527	CcSEcCtD
Methylprednisolone—Headache—Bromocriptine—type 2 diabetes mellitus	8.58e-05	0.000527	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.57e-05	0.000527	CcSEcCtD
Methylprednisolone—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.57e-05	0.000526	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.45e-05	0.000519	CcSEcCtD
Methylprednisolone—Paraesthesia—Metformin—type 2 diabetes mellitus	8.45e-05	0.000519	CcSEcCtD
Methylprednisolone—Fludrocortisone—NR3C1—type 2 diabetes mellitus	8.44e-05	0.0155	CrCbGaD
Methylprednisolone—Flunisolide—NR3C1—type 2 diabetes mellitus	8.44e-05	0.0155	CrCbGaD
Methylprednisolone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	8.44e-05	0.0155	CrCbGaD
Methylprednisolone—Confusional state—Losartan—type 2 diabetes mellitus	8.42e-05	0.000518	CcSEcCtD
Methylprednisolone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.41e-05	0.000517	CcSEcCtD
Methylprednisolone—Exemestane—CYP3A4—type 2 diabetes mellitus	8.41e-05	0.0155	CrCbGaD
Methylprednisolone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.35e-05	0.000513	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.35e-05	0.000513	CcSEcCtD
Methylprednisolone—Paramethasone—NR3C1—type 2 diabetes mellitus	8.33e-05	0.0153	CrCbGaD
Methylprednisolone—Infection—Losartan—type 2 diabetes mellitus	8.3e-05	0.00051	CcSEcCtD
Methylprednisolone—Hypotension—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.00051	CcSEcCtD
Methylprednisolone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.28e-05	0.000509	CcSEcCtD
Methylprednisolone—Dyspepsia—Metformin—type 2 diabetes mellitus	8.28e-05	0.000509	CcSEcCtD
Methylprednisolone—Shock—Losartan—type 2 diabetes mellitus	8.22e-05	0.000505	CcSEcCtD
Methylprednisolone—Urticaria—Valsartan—type 2 diabetes mellitus	8.21e-05	0.000504	CcSEcCtD
Methylprednisolone—Ciclesonide—NR3C1—type 2 diabetes mellitus	8.2e-05	0.0151	CrCbGaD
Methylprednisolone—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.19e-05	0.000503	CcSEcCtD
Methylprednisolone—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.17e-05	0.000502	CcSEcCtD
Methylprednisolone—Tachycardia—Losartan—type 2 diabetes mellitus	8.15e-05	0.000501	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.14e-05	0.0005	CcSEcCtD
Methylprednisolone—Nausea—Bromocriptine—type 2 diabetes mellitus	8.14e-05	0.0005	CcSEcCtD
Methylprednisolone—Fluorometholone—NR3C1—type 2 diabetes mellitus	8.13e-05	0.015	CrCbGaD
Methylprednisolone—Fatigue—Metformin—type 2 diabetes mellitus	8.11e-05	0.000498	CcSEcCtD
Methylprednisolone—Urticaria—Orlistat—type 2 diabetes mellitus	8.11e-05	0.000498	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.09e-05	0.000497	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.08e-05	0.000496	CcSEcCtD
Methylprednisolone—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.07e-05	0.000496	CcSEcCtD
Methylprednisolone—Asthenia—Gliclazide—type 2 diabetes mellitus	8.07e-05	0.000496	CcSEcCtD
Methylprednisolone—Angioedema—Ramipril—type 2 diabetes mellitus	8.02e-05	0.000493	CcSEcCtD
Methylprednisolone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.00049	CcSEcCtD
Methylprednisolone—Vomiting—Glyburide—type 2 diabetes mellitus	7.96e-05	0.000489	CcSEcCtD
Methylprednisolone—Pruritus—Gliclazide—type 2 diabetes mellitus	7.95e-05	0.000489	CcSEcCtD
Methylprednisolone—Malaise—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000486	CcSEcCtD
Methylprednisolone—Rash—Glyburide—type 2 diabetes mellitus	7.89e-05	0.000485	CcSEcCtD
Methylprednisolone—Dermatitis—Glyburide—type 2 diabetes mellitus	7.89e-05	0.000485	CcSEcCtD
Methylprednisolone—Vertigo—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000485	CcSEcCtD
Methylprednisolone—Syncope—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000484	CcSEcCtD
Methylprednisolone—Headache—Glyburide—type 2 diabetes mellitus	7.84e-05	0.000482	CcSEcCtD
Methylprednisolone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.00048	CcSEcCtD
Methylprednisolone—Hypotension—Losartan—type 2 diabetes mellitus	7.81e-05	0.00048	CcSEcCtD
Methylprednisolone—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.75e-05	0.000476	CcSEcCtD
Methylprednisolone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000474	CcSEcCtD
Methylprednisolone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.69e-05	0.000473	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.69e-05	0.000473	CcSEcCtD
Methylprednisolone—Fatigue—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.00047	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.61e-05	0.000468	CcSEcCtD
Methylprednisolone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.61e-05	0.000468	CcSEcCtD
Methylprednisolone—Convulsion—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000467	CcSEcCtD
Methylprednisolone—Insomnia—Losartan—type 2 diabetes mellitus	7.56e-05	0.000464	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	7.54e-05	0.0139	CrCbGaD
Methylprednisolone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.52e-05	0.000462	CcSEcCtD
Methylprednisolone—Paraesthesia—Losartan—type 2 diabetes mellitus	7.5e-05	0.000461	CcSEcCtD
Methylprednisolone—Urticaria—Metformin—type 2 diabetes mellitus	7.47e-05	0.000459	CcSEcCtD
Methylprednisolone—Myalgia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000459	CcSEcCtD
Methylprednisolone—Arthralgia—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000459	CcSEcCtD
Methylprednisolone—Anxiety—Ramipril—type 2 diabetes mellitus	7.45e-05	0.000458	CcSEcCtD
Methylprednisolone—Nausea—Glyburide—type 2 diabetes mellitus	7.44e-05	0.000457	CcSEcCtD
Methylprednisolone—Abdominal pain—Metformin—type 2 diabetes mellitus	7.44e-05	0.000457	CcSEcCtD
Methylprednisolone—Dizziness—Gliclazide—type 2 diabetes mellitus	7.43e-05	0.000457	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.42e-05	0.000456	CcSEcCtD
Methylprednisolone—Asthenia—Valsartan—type 2 diabetes mellitus	7.41e-05	0.000455	CcSEcCtD
Methylprednisolone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	7.39e-05	0.0136	CrCbGaD
Methylprednisolone—Discomfort—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000454	CcSEcCtD
Methylprednisolone—Dyspepsia—Losartan—type 2 diabetes mellitus	7.35e-05	0.000452	CcSEcCtD
Methylprednisolone—Asthenia—Orlistat—type 2 diabetes mellitus	7.32e-05	0.00045	CcSEcCtD
Methylprednisolone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.000449	CcSEcCtD
Methylprednisolone—Pruritus—Valsartan—type 2 diabetes mellitus	7.31e-05	0.000449	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000446	CcSEcCtD
Methylprednisolone—Confusional state—Ramipril—type 2 diabetes mellitus	7.22e-05	0.000444	CcSEcCtD
Methylprednisolone—Pruritus—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000444	CcSEcCtD
Methylprednisolone—Fatigue—Losartan—type 2 diabetes mellitus	7.2e-05	0.000443	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.16e-05	0.00044	CcSEcCtD
Methylprednisolone—Vomiting—Gliclazide—type 2 diabetes mellitus	7.15e-05	0.000439	CcSEcCtD
Methylprednisolone—Hydrocortisone—SHBG—type 2 diabetes mellitus	7.13e-05	0.0131	CrCbGaD
Methylprednisolone—Rash—Gliclazide—type 2 diabetes mellitus	7.09e-05	0.000436	CcSEcCtD
Methylprednisolone—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.08e-05	0.000435	CcSEcCtD
Methylprednisolone—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.07e-05	0.000434	CcSEcCtD
Methylprednisolone—Urticaria—Irbesartan—type 2 diabetes mellitus	7.05e-05	0.000433	CcSEcCtD
Methylprednisolone—Shock—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000433	CcSEcCtD
Methylprednisolone—Headache—Gliclazide—type 2 diabetes mellitus	7.04e-05	0.000433	CcSEcCtD
Methylprednisolone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.02e-05	0.000432	CcSEcCtD
Methylprednisolone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000431	CcSEcCtD
Methylprednisolone—Tachycardia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.00043	CcSEcCtD
Methylprednisolone—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.98e-05	0.000429	CcSEcCtD
Methylprednisolone—Skin disorder—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000428	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000426	CcSEcCtD
Methylprednisolone—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.88e-05	0.000423	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.83e-05	0.00042	CcSEcCtD
Methylprednisolone—Dizziness—Valsartan—type 2 diabetes mellitus	6.83e-05	0.00042	CcSEcCtD
Methylprednisolone—Dizziness—Orlistat—type 2 diabetes mellitus	6.75e-05	0.000415	CcSEcCtD
Methylprednisolone—Asthenia—Metformin—type 2 diabetes mellitus	6.75e-05	0.000415	CcSEcCtD
Methylprednisolone—Hypotension—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000411	CcSEcCtD
Methylprednisolone—Nausea—Gliclazide—type 2 diabetes mellitus	6.68e-05	0.00041	CcSEcCtD
Methylprednisolone—Pruritus—Metformin—type 2 diabetes mellitus	6.65e-05	0.000409	CcSEcCtD
Methylprednisolone—Urticaria—Losartan—type 2 diabetes mellitus	6.64e-05	0.000408	CcSEcCtD
Methylprednisolone—Triamcinolone—NR3C1—type 2 diabetes mellitus	6.63e-05	0.0122	CrCbGaD
Methylprednisolone—Abdominal pain—Losartan—type 2 diabetes mellitus	6.6e-05	0.000406	CcSEcCtD
Methylprednisolone—Vomiting—Valsartan—type 2 diabetes mellitus	6.57e-05	0.000404	CcSEcCtD
Methylprednisolone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000402	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.53e-05	0.000401	CcSEcCtD
Methylprednisolone—Rash—Valsartan—type 2 diabetes mellitus	6.51e-05	0.0004	CcSEcCtD
Methylprednisolone—Dermatitis—Valsartan—type 2 diabetes mellitus	6.51e-05	0.0004	CcSEcCtD
Methylprednisolone—Vomiting—Orlistat—type 2 diabetes mellitus	6.49e-05	0.000399	CcSEcCtD
Methylprednisolone—Insomnia—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000398	CcSEcCtD
Methylprednisolone—Headache—Valsartan—type 2 diabetes mellitus	6.47e-05	0.000398	CcSEcCtD
Methylprednisolone—Diarrhoea—Metformin—type 2 diabetes mellitus	6.44e-05	0.000395	CcSEcCtD
Methylprednisolone—Rash—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000395	CcSEcCtD
Methylprednisolone—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000395	CcSEcCtD
Methylprednisolone—Dermatitis—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000395	CcSEcCtD
Methylprednisolone—Headache—Orlistat—type 2 diabetes mellitus	6.39e-05	0.000393	CcSEcCtD
Methylprednisolone—Asthenia—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000391	CcSEcCtD
Methylprednisolone—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000387	CcSEcCtD
Methylprednisolone—Pruritus—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000386	CcSEcCtD
Methylprednisolone—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	6.27e-05	0.0115	CrCbGaD
Methylprednisolone—Dexamethasone—NOS2—type 2 diabetes mellitus	6.25e-05	0.0115	CrCbGaD
Methylprednisolone—Dizziness—Metformin—type 2 diabetes mellitus	6.22e-05	0.000382	CcSEcCtD
Methylprednisolone—Fatigue—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000379	CcSEcCtD
Methylprednisolone—Cortisone acetate—CYP3A4—type 2 diabetes mellitus	6.17e-05	0.0114	CrCbGaD
Methylprednisolone—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.15e-05	0.000378	CcSEcCtD
Methylprednisolone—Nausea—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000377	CcSEcCtD
Methylprednisolone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.07e-05	0.000373	CcSEcCtD
Methylprednisolone—Nausea—Orlistat—type 2 diabetes mellitus	6.06e-05	0.000373	CcSEcCtD
Methylprednisolone—Prednisone—NR3C1—type 2 diabetes mellitus	6.01e-05	0.0111	CrCbGaD
Methylprednisolone—Asthenia—Losartan—type 2 diabetes mellitus	5.99e-05	0.000368	CcSEcCtD
Methylprednisolone—Vomiting—Metformin—type 2 diabetes mellitus	5.98e-05	0.000367	CcSEcCtD
Methylprednisolone—Medroxyprogesterone Acetate—NR3C1—type 2 diabetes mellitus	5.98e-05	0.011	CrCbGaD
Methylprednisolone—Rash—Metformin—type 2 diabetes mellitus	5.93e-05	0.000364	CcSEcCtD
Methylprednisolone—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	5.93e-05	0.0109	CrCbGaD
Methylprednisolone—Dermatitis—Metformin—type 2 diabetes mellitus	5.93e-05	0.000364	CcSEcCtD
Methylprednisolone—Pruritus—Losartan—type 2 diabetes mellitus	5.91e-05	0.000363	CcSEcCtD
Methylprednisolone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000363	CcSEcCtD
Methylprednisolone—Headache—Metformin—type 2 diabetes mellitus	5.89e-05	0.000362	CcSEcCtD
Methylprednisolone—Dizziness—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000361	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.86e-05	0.00036	CcSEcCtD
Methylprednisolone—Budesonide—CYP3A4—type 2 diabetes mellitus	5.83e-05	0.0107	CrCbGaD
Methylprednisolone—Diarrhoea—Losartan—type 2 diabetes mellitus	5.72e-05	0.000351	CcSEcCtD
Methylprednisolone—Urticaria—Ramipril—type 2 diabetes mellitus	5.69e-05	0.00035	CcSEcCtD
Methylprednisolone—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000348	CcSEcCtD
Methylprednisolone—Vomiting—Irbesartan—type 2 diabetes mellitus	5.64e-05	0.000347	CcSEcCtD
Methylprednisolone—Rash—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.000344	CcSEcCtD
Methylprednisolone—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000344	CcSEcCtD
Methylprednisolone—Nausea—Metformin—type 2 diabetes mellitus	5.59e-05	0.000343	CcSEcCtD
Methylprednisolone—Headache—Irbesartan—type 2 diabetes mellitus	5.56e-05	0.000342	CcSEcCtD
Methylprednisolone—Prednisolone—NR3C1—type 2 diabetes mellitus	5.54e-05	0.0102	CrCbGaD
Methylprednisolone—Dizziness—Losartan—type 2 diabetes mellitus	5.52e-05	0.000339	CcSEcCtD
Methylprednisolone—Betamethasone—NR3C1—type 2 diabetes mellitus	5.43e-05	0.01	CrCbGaD
Methylprednisolone—Vomiting—Losartan—type 2 diabetes mellitus	5.31e-05	0.000326	CcSEcCtD
Methylprednisolone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000324	CcSEcCtD
Methylprednisolone—Nausea—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000324	CcSEcCtD
Methylprednisolone—Rash—Losartan—type 2 diabetes mellitus	5.27e-05	0.000324	CcSEcCtD
Methylprednisolone—Dermatitis—Losartan—type 2 diabetes mellitus	5.26e-05	0.000323	CcSEcCtD
Methylprednisolone—Headache—Losartan—type 2 diabetes mellitus	5.23e-05	0.000322	CcSEcCtD
Methylprednisolone—Asthenia—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000316	CcSEcCtD
Methylprednisolone—Pruritus—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000311	CcSEcCtD
Methylprednisolone—Alclometasone—CYP3A4—type 2 diabetes mellitus	5.02e-05	0.00925	CrCbGaD
Methylprednisolone—Nausea—Losartan—type 2 diabetes mellitus	4.96e-05	0.000305	CcSEcCtD
Methylprednisolone—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000301	CcSEcCtD
Methylprednisolone—Flunisolide—CYP3A4—type 2 diabetes mellitus	4.89e-05	0.009	CrCbGaD
Methylprednisolone—Paramethasone—CYP3A4—type 2 diabetes mellitus	4.83e-05	0.00889	CrCbGaD
Methylprednisolone—Ciclesonide—CYP3A4—type 2 diabetes mellitus	4.75e-05	0.00875	CrCbGaD
Methylprednisolone—Dizziness—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000291	CcSEcCtD
Methylprednisolone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	4.71e-05	0.00868	CrCbGaD
Methylprednisolone—Vomiting—Ramipril—type 2 diabetes mellitus	4.55e-05	0.00028	CcSEcCtD
Methylprednisolone—Rash—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000278	CcSEcCtD
Methylprednisolone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000277	CcSEcCtD
Methylprednisolone—Headache—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000276	CcSEcCtD
Methylprednisolone—Nausea—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000261	CcSEcCtD
Methylprednisolone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	4.24e-05	0.0078	CrCbGaD
Methylprednisolone—Dexamethasone—ABCC2—type 2 diabetes mellitus	4.14e-05	0.00763	CrCbGaD
Methylprednisolone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	3.84e-05	0.00707	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.84e-05	0.000869	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	3.82e-05	0.000864	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	3.78e-05	0.000856	CbGpPWpGaD
Methylprednisolone—Triamcinolone—PTGS2—type 2 diabetes mellitus	3.76e-05	0.00693	CrCbGaD
Methylprednisolone—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.72e-05	0.000842	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	3.63e-05	0.000821	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.6e-05	0.000815	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	3.6e-05	0.000815	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	3.57e-05	0.000807	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	3.56e-05	0.000805	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.55e-05	0.000804	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	3.55e-05	0.000803	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.52e-05	0.000798	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	3.51e-05	0.000794	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	3.5e-05	0.000791	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	3.49e-05	0.00079	CbGpPWpGaD
Methylprednisolone—Prednisone—CYP3A4—type 2 diabetes mellitus	3.48e-05	0.00642	CrCbGaD
Methylprednisolone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	3.47e-05	0.000786	CbGpPWpGaD
Methylprednisolone—Medroxyprogesterone Acetate—CYP3A4—type 2 diabetes mellitus	3.47e-05	0.00638	CrCbGaD
Methylprednisolone—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	3.43e-05	0.00632	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.42e-05	0.000774	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.42e-05	0.000774	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	3.29e-05	0.000745	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	3.29e-05	0.000745	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.28e-05	0.000742	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.27e-05	0.00074	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	3.24e-05	0.000734	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.24e-05	0.000732	CbGpPWpGaD
Methylprednisolone—Prednisolone—CYP3A4—type 2 diabetes mellitus	3.21e-05	0.00591	CrCbGaD
Methylprednisolone—Dexamethasone—NR3C1—type 2 diabetes mellitus	3.16e-05	0.00581	CrCbGaD
Methylprednisolone—Betamethasone—CYP3A4—type 2 diabetes mellitus	3.15e-05	0.00579	CrCbGaD
Methylprednisolone—Betamethasone—PTGS2—type 2 diabetes mellitus	3.08e-05	0.00567	CrCbGaD
Methylprednisolone—Prednisone—ALB—type 2 diabetes mellitus	3.04e-05	0.0056	CrCbGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	3.03e-05	0.000685	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	3.02e-05	0.000682	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.99e-05	0.000677	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.97e-05	0.000673	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.94e-05	0.000665	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.93e-05	0.000664	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	2.91e-05	0.00535	CrCbGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.9e-05	0.000656	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.8e-05	0.000634	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.8e-05	0.000634	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	2.79e-05	0.000631	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	2.78e-05	0.000629	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.7e-05	0.000612	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.7e-05	0.00061	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.62e-05	0.000592	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	2.59e-05	0.000587	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.59e-05	0.000587	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.47e-05	0.000559	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	2.46e-05	0.00452	CrCbGaD
Methylprednisolone—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.44e-05	0.000552	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	2.44e-05	0.000552	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.33e-05	0.000527	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.31e-05	0.000523	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.31e-05	0.000523	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.29e-05	0.000518	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.26e-05	0.000512	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.25e-05	0.00051	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.25e-05	0.000509	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.23e-05	0.000505	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.23e-05	0.000504	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.22e-05	0.000503	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.21e-05	0.000499	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.16e-05	0.000489	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.16e-05	0.000489	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.15e-05	0.000486	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.15e-05	0.000486	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.12e-05	0.00048	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.1e-05	0.000475	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.09e-05	0.000472	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.07e-05	0.000469	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.04e-05	0.000461	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.04e-05	0.000461	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.01e-05	0.000454	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2e-05	0.000452	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.97e-05	0.000445	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.97e-05	0.000445	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.97e-05	0.000445	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.97e-05	0.000445	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.97e-05	0.000445	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.9e-05	0.000431	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.9e-05	0.000429	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.84e-05	0.000416	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	1.83e-05	0.00337	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.83e-05	0.000413	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.8e-05	0.000407	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.8e-05	0.000407	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—type 2 diabetes mellitus	1.79e-05	0.0033	CrCbGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.76e-05	0.000398	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.75e-05	0.000397	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.74e-05	0.000394	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.72e-05	0.000389	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.71e-05	0.000388	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.67e-05	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.67e-05	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.67e-05	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.67e-05	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.65e-05	0.000373	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.6e-05	0.000363	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.6e-05	0.000363	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.58e-05	0.000357	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.56e-05	0.000354	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.54e-05	0.000349	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.54e-05	0.000349	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.53e-05	0.000347	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.52e-05	0.000343	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.5e-05	0.00034	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.5e-05	0.00034	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.49e-05	0.000338	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.49e-05	0.000337	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.49e-05	0.000337	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.49e-05	0.000337	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.44e-05	0.000326	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.43e-05	0.000324	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.42e-05	0.000322	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.42e-05	0.000322	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.42e-05	0.000322	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.4e-05	0.000317	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.38e-05	0.000312	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.37e-05	0.000311	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.37e-05	0.00031	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.36e-05	0.000308	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.34e-05	0.000304	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.31e-05	0.000297	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.3e-05	0.000294	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.28e-05	0.00029	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.28e-05	0.00029	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.27e-05	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.27e-05	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.27e-05	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.27e-05	0.000287	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.25e-05	0.000284	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.25e-05	0.000284	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.21e-05	0.000275	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.21e-05	0.000274	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.21e-05	0.000274	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.21e-05	0.000274	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.21e-05	0.000274	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.21e-05	0.000274	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.17e-05	0.000265	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.16e-05	0.000262	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.13e-05	0.000256	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.11e-05	0.000251	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.11e-05	0.000251	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.09e-05	0.000246	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.08e-05	0.000244	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.07e-05	0.000243	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.05e-05	0.000239	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.03e-05	0.000234	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.03e-05	0.000234	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.03e-05	0.000233	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.03e-05	0.000233	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.03e-05	0.000233	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.01e-05	0.000229	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.01e-05	0.000228	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.01e-05	0.000228	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.01e-05	0.000228	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1e-05	0.000226	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.87e-06	0.000223	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.87e-06	0.000223	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.82e-06	0.000222	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	9.71e-06	0.00022	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	9.67e-06	0.000219	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.53e-06	0.000216	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.51e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.51e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.34e-06	0.000211	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.18e-06	0.000208	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.18e-06	0.000208	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.18e-06	0.000208	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.03e-06	0.000204	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.03e-06	0.000204	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.03e-06	0.000204	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	8.86e-06	0.0002	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	8.78e-06	0.000199	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.63e-06	0.000195	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.61e-06	0.000195	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.59e-06	0.000194	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.26e-06	0.000187	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.16e-06	0.000185	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.16e-06	0.000185	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.08e-06	0.000183	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.96e-06	0.00018	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.83e-06	0.000177	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.83e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.81e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.81e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.81e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.81e-06	0.000177	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.48e-06	0.000169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.96e-06	0.000157	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.75e-06	0.000153	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.75e-06	0.000153	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.72e-06	0.000152	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.63e-06	0.00015	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.49e-06	0.000147	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.43e-06	0.000146	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.36e-06	0.000144	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.36e-06	0.000144	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.26e-06	0.000142	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.24e-06	0.000141	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.2e-06	0.00014	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.16e-06	0.000139	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.14e-06	0.000139	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.05e-06	0.000137	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.01e-06	0.000136	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.99e-06	0.000136	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.98e-06	0.000135	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.84e-06	0.000132	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.76e-06	0.00013	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.56e-06	0.000126	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.56e-06	0.000126	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.56e-06	0.000126	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.53e-06	0.000125	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.46e-06	0.000124	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.43e-06	0.000123	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.41e-06	0.000122	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.29e-06	0.00012	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.25e-06	0.000119	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.17e-06	0.000117	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.15e-06	0.000116	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.09e-06	0.000115	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.09e-06	0.000115	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.03e-06	0.000114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.03e-06	0.000114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.82e-06	0.000109	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.82e-06	0.000109	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.48e-06	0.000101	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.4e-06	9.95e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	4.24e-06	9.6e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.16e-06	9.4e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.16e-06	9.4e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.14e-06	9.36e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.08e-06	9.24e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.03e-06	9.12e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.96e-06	8.97e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.86e-06	8.73e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.86e-06	8.73e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.86e-06	8.72e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.78e-06	8.56e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.7e-06	8.38e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.69e-06	8.35e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.6e-06	8.14e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.55e-06	8.03e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.53e-06	7.98e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.41e-06	7.71e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.34e-06	7.56e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.24e-06	7.32e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.18e-06	7.2e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.17e-06	7.18e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.14e-06	7.09e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.76e-06	6.25e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.71e-06	6.13e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.48e-06	5.62e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.38e-06	5.38e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.38e-06	5.38e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.17e-06	4.92e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.77e-06	4.01e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	2.47e-05	CbGpPWpGaD
